Financhill
Sell
41

CPS Quote, Financials, Valuation and Earnings

Last price:
$14.28
Seasonality move :
-5.79%
Day range:
$13.97 - $14.46
52-week range:
$11.24 - $19.21
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.09x
P/B ratio:
--
Volume:
230.6K
Avg. volume:
260.3K
1-year change:
-0.07%
Market cap:
$245.5M
Revenue:
$2.7B
EPS (TTM):
-$4.54

Earnings Data

Next earnings date for CPS
May 06
2025
Most recent earnings per share
$2.24
Beat by $2.18
(Feb 13/2025)
Consensus Estimate
$0.06
(Feb 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CPS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/06/2025 Q1 $670M -- -- -$0.93 --
02/13/2025 Q4 $679.9M $660.8M $2.24 $0.06 $2.18
10/31/2024 Q3 $663M $685.4M -$0.63 -$1.18 $0.55
08/01/2024 Q2 $735.5M $708.4M -$4.34 -$1.06 -$3.28
05/06/2024 Q1 $672.5M $676.4M -$1.81 -$2.01 $0.20
02/15/2024 Q4 $682.8M $673.6M -$3.16 -$1.92 -$1.24
11/02/2023 Q3 -- -- $0.65 -$0.82 $1.47
08/03/2023 Q2 -- -- -$1.61 -$1.86 $0.25
05/03/2023 Q1 -- -- -$7.57 -$1.89 -$5.68
02/16/2023 Q4 -- -- -$5.12 -$0.78 -$4.34
11/01/2022 Q3 -- -- -$1.90 -$1.69 -$0.22
08/04/2022 Q2 -- -- -$1.93 -$3.48 $1.55
05/05/2022 Q1 -- -- -$3.58 -$2.55 -$1.03
02/17/2022 Q4 -- -- -$5.98 -$2.71 -$3.28
11/03/2021 Q3 -- -- -$7.20 -$3.13 -$4.07
08/04/2021 Q2 -- -- -$3.73 -$3.48 -$0.25
05/06/2021 Q1 -- -- -$2.00 -$0.85 -$1.15
02/17/2021 Q4 -- -- -$1.61 $0.17 -$1.78
11/05/2020 Q3 -- -- $0.26 -$1.64 $1.90
08/04/2020 Q2 -- -- -$7.93 -$7.83 -$0.10
05/11/2020 Q1 -- -- -$6.55 -$0.81 -$5.74
02/24/2020 Q4 -- -- -$4.00 -$0.60 -$3.40
11/05/2019 Q3 -- -- -$0.29 $0.82 -$1.11
08/01/2019 Q2 -- -- $8.36 $0.96 $7.40
05/01/2019 Q1 -- -- -$0.31 $1.00 -$1.31
02/14/2019 Q4 -- -- -$1.30 $1.93 -$3.23
11/01/2018 Q3 -- -- $1.77 -- --
07/31/2018 Q2 -- -- $2.28 -- --
05/01/2018 Q1 -- -- $3.07 -- --
02/15/2018 Q4 -- -- $1.53 -- --
10/31/2017 Q3 -- -- $1.32 -- --
08/03/2017 Q2 -- -- $2.14 -- --
05/03/2017 Q1 -- -- $2.20 -- --
02/16/2017 Q4 -- -- $1.65 -- --
11/01/2016 Q3 -- -- $1.94 -- --
07/29/2016 Q2 -- -- $2.16 -- --
05/03/2016 Q1 -- -- $1.67 -- --
02/22/2016 Q4 -- -- $1.16 -- --
11/04/2015 Q3 -- -- $1.78 -- --
07/31/2015 Q2 -- -- $1.98 -- --
05/07/2015 Q1 -- -- $1.15 -- --

Cooper-Standard Holdings Earnings Questions

  • How Much did Cooper-Standard Holdings Generate in Revenue Last Quarter?

    Cooper-Standard Holdings reported $660.8M worth of top line sales in its most recent quarter.

  • Did Cooper-Standard Holdings Beat Earnings Last Quarter?

    Cooper-Standard Holdings announced earnings per share of $2.24 which represents a beat of analyst forecast a $0.06 per share.

  • Is Cooper-Standard Holdings Profitable?

    Cooper-Standard Holdings reported $82M that represents $4.66 per share over the last quarter.

  • What is the Analyst Consensus for Cooper-Standard Holdings EPS Next Year?

    Cooper-Standard Holdings's earnings are forecast to decrease from -$4.48 per share to -$3.00 per share next year representing a decrease of -85.27%.

  • When is Cooper-Standard Holdings's Earnings Date?

    Cooper-Standard Holdings's next earnings date is May 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock